recombinant hepatitis B vaccine (CHO cell) (NCPC GeneTech Biotechnology Development)

N/A

Report date: 2025/01/26 16:51:27

Base Information

Drug Namerecombinant hepatitis B vaccine (CHO cell) (NCPC GeneTech Biotechnology Development)
Drug Alias NamerhHBsAG vaccine (NCPC GeneTech Biotechnology Development)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionHBsAg modulators
TargetsHepatitis B Surface Antigens
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNcpc Genetech Biotechnology Development
China Registration ClassN/A

Develop Information

Active CompaniesNcpc Genetech Biotechnology Development
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A